Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

Experts have sounded the alarm about a 'very concerning' new form of bird flu spreading in Nevada, which they fear could ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

MediSave can be used to pay for the cost of the vaccine after subsidies from 2026. Read more at straitstimes.com.

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...